Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 4

1(16.7%)

6Total

N/A(5)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07497867Recruiting

Long-term Prospective Study of Korean CADASIL Patients

Role: collaborator

NCT02823808Phase 4Unknown

Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function

Role: collaborator

NCT01264575Not ApplicableCompleted

ED50 and ED95 of Intrathecal Bupivacaine With or Without Epinephrine for Total Knee Replacement Arthroplasty

Role: lead

NCT01267916Not ApplicableCompleted

Intrinsic PEEP During Mechanical Ventilation of Patients With Obesity

Role: lead

NCT01291186Not ApplicableCompleted

Effect of Body-mass Index (BMI) on Median Effective Dose of Intrathecal Hyperbaric Bupivacaine

Role: lead

NCT01261078Not ApplicableCompleted

The Bupivacaine Dose Sparing Effect of Intrathecal Epinephrine

Role: lead

NCT01269099Not ApplicableCompleted

Hypokalemia and Intravenous Patient Controlled Analgesia

Role: lead

All 7 trials loaded